Clinical Trial Update: A Study Comparing Mircera and Epoetin Beta for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease. [Phase 3]

View source ↗

Summary

Phase 3 study comparing Mircera (methoxy polyethylene glycol-epoetin beta) with epoetin beta for anemia in dialysis-dependent chronic kidney disease patients; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)
• epoetin beta (epoetin beta)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED